Another Recall- Johnson & Johnson Recalls Infant Tylenol

How can we ensure that the items we purchase are safe for our children?  As parents today, we have to be on guard continually in order to protect our children.  And, what a job that seems to be lately, with so many recalls.  So once again, I pose the question, is there anything safe for our babies anymore?

The latest information that needs to be in the hands of all parents is that Johnson & Johnson has just issued another recall, this time the recall is for all Infants’ Tylenol, due to a problem with the new bottle design and the bottle’s cap, ironically designed to ensure accurate dosing. However, the new bottle design interferes with parents and caregivers accessing the proper dosage for the infant.

McNeil Consumer Healthcare, a Division of McNeil-PPC, Inc., a unit of Johnson & Johnson, is recalling, at the wholesale and retail levels, seven lots of its Infants’ Tylenol Oral Suspension. Some 574,000 bottles of the 1-ounce grape-flavored medication, distributed nationwide in the United States, are involved in the recall. Infants’ Tylenol is an over-the-counter (OTC) product indicated as a pain reliever and fever reducer.

McNeil received approximately 17 complaints from consumers who reported difficulty using the Infants’ Tylenol SimpleMeasure dosing system, which includes a dosing syringe that a parent or caregiver inserts into a protective cover, or “flow restrictor,” at the top of the bottle to measure the proper dose. In some cases, the flow restrictor was pushed into the bottle when inserting the syringe. This new system was a new design and just introduced 3 months ago.

According to a report by Reuters on February 17, Johnson & Johnson says, “The recall is from stores and wholesalers; consumers can still use the product provided that the protective cover at the top of the bottle remains in place.”

The recall involves all Infants’ Tylenol Oral Suspension, 1-ounce, grape, and includes UPC 300450122308 and lot numbers BIL0U00, BIL0V00, BIL3500, BJL2D00, BJL2E00, BJL2T00, and BJL2U00.

For the moment, no date has been set for the product’s return to the marketplace. J&J is looking at possibly redesigning the over-the-counter medicine’s bottle.  McNeil spokeswoman Bonnie Jacobs said it was too early to discuss when the Infants’ Tylenol will return to the market. “We are looking at various alternatives for the redesign of the dosing system and will set a timeline … once we’ve reviewed all the options,” she said, wrote the Christian Science Monitor.

This recall only involves the infant Tylenol, intended for children 2 years and under.  It does not involve the Children’s Tylenol products that are for children two years of age and older and continue to remain available.

To date no adverse events connected to this recall have been reported and the risk of a serious adverse medical event is considered remote.

Consumers can request a refund by visiting www.tylenol.com or contacting McNeil, toll-free, at 1.888.222.6036 , Monday through Friday, from 8:00 a.m. to 8:00 p.m., Eastern Time (ET), and Saturday and Sunday, from 9:00 a.m. to 5:00 p.m. ET.

Since September 2009, McNeil’s Consumer Healthcare unit has issued about 25 product recalls.



,

No comments yet.

Leave a Reply

GET HELP NOW!
  • This field is for validation purposes and should be left unchanged.
Latest Drug Injury News

Underground Railway Dust May Pose Health Risk

Travelling or working on an underground railway for sustained period of time could have health implications due to concentrations of metal-rich microscopic dust particles.

New Study Helps Understand Why Health Care Costs On The Rise

Although many believe is it medical malpractice suites that are causing the increase in the health care costs, it is actually the fear of them that is partly to blame. Doctors are ordering unnecessary tests and procedures for fear of a patient filing a claim down the road

FDA Issues New Warnings Concerning Tolvaptan

The FDA has issued a drug safety communication concerning Tolvaptan, a selective vasopression V2-receptor antagonist used in heart failure patients to treat clinically significant hypervolemic and euvolemic hyponatremia.

New Antiepileptic Drug Causes Blue Discoloration And Vision Trouble

An antiepileptic drug to hit the market has been known to cause vision troubles and skin discoloration. Almost all patients experienced gray/blue skin discoloration who had been taking the pill for two years. More information is needed to better understand the occurrences.

Medical Mattresses Pose Risk Of Infection And Contamination

The FDA warns that medical mattresses may not be as clean as once perceived. Routine checks on mattresses are advised as any rips, tears, or excessive wear alter the efficacy. The medical mattresses as well as the covers have an expected life depending on the manufacturer, which should not go unnoticed.

Latest Medical Device Injury News

Women 30% More Likely To Need Repeat Hip Implant Surgery

Doctors traditionally believed the larger the size of the implant, the more protective it was against failure, according to Sedrakyan. However, he said his study found regardless of size, women had a higher rate of revision occurrence, so some other factor besides the actual implants may be leading to this effect.

Transvaginal Mesh Lawsuits – Who Is At Fault?

For some women a pelvic transvaginal mesh product has been a god sent.  To be able to resume a full active life, without the worry of a leaky bladder, is a true miracle for some women.  And, this only became possible with the help of pelvic mesh. The mesh is most commonly used after pelvic [...]

Metal-on-Metal Hip Implants Cause Soft Tissue Damage Says FDA

Hip joint deterioration can lead to pain, stiffness or difficulty walking. When these symptoms do not respond to conservative treatment, such as physical therapy, patients may be advised to undergo total hip replacement or hip resurfacing. As part of this treatment, they may receive a “metal-on-metal” hip implant in which the “ball and socket” of [...]

Ethicon Recalls Surgical Stapler

The FDA has announced a voluntary global recall of more than 157,000 Ethicon surgical staplers, due to problems with incomplete firing strokes that may cause faulty staple formation, potentially resulting in painful and severe internal complications for the patient. An Ethicon surgical stapler recall was first announced in August, after reports surfaced where surgeons experienced [...]

Another Device Maker Investigated By DOJ

Earlier this month, cardiovascular device maker Abiomed announced that the US Attorney’s Office was investigating the company’s marketing and labeling of the Impella 2.5 circulatory support device. According to Forbes, the announcement confirmed rumors that had been circulating for at least two weeks, though in the press release the company said it had just been [...]